223
Views
31
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Laryngeal Carcinoma
Multivariate Analysis of Prognostic Factors in 1 252 Consecutive Patients Treated with Primary Radiotherapy

, &
Pages 771-778 | Received 22 Apr 2003, Accepted 15 Aug 2003, Published online: 08 Jul 2009

References

  • Johansen LV, Grau C, Overgaard J. Supraglottic carcinoma. Patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int J Radiat Oncol Biol Phys 2002; 53: 948–58.
  • Johansen LV, Grau C, Overgaard J. Glottic carcinoma-patterns of failure and salvage treatment after curative radio-therapy in 861 consecutive patients. Radiother Oncol 2002; 63: 257–67.
  • Cancer incidence in Denmark 1984. Copenhagen: Danish Cancer Society; 1987.
  • Cancer incidence in Denmark 1998. Copenhagen: The Danish National Board of Health; 2002.
  • Hansen HS. Neoplasma malignum laryngis. Thesis. Copenha-gen: Polyteknisk Forlag; 1975.
  • Jorgensen K. Carcinoma laryngis. Thesis. Aarhus University; 1976.
  • Lund C, Sogaard H, Jorgensen K, Elbrond O, Hjelm-Hansen M, Andersen AR Histological grading of epidermoid carcino-mas in the head and neck. Dan Med Bull 1977; 24: 162–6.
  • TNM classification of malignant tumors: third enlarged and revised edition. In: Harmer MH, ed. Geneva: UICC; 1982. p. 27–32.
  • Overgaard J, Hansen HS, Andersen AP, et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065–8.
  • Overgaard J, Hansen HS, Overgaard M, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 1998; 46: 135–46.
  • Hansen HS, Rygard J, Andersen AP, et al. Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma. A study initiated by the Danish Society of Head and Neck Cancer. Acta Oncol 1987; 26: 13–8.
  • Jorgensen K, Godballe C, Hansen O, Bastholt L. Cancer of the larynx-treatment results after primary radiotherapy with salvage surgery in a series of 1 005 patients. Acta Oncol 2002; 41: 69–76.
  • Carl J, Andersen LJ, Pedersen M, Greisen 0. Prognostic factors of local control after radiotherapy in Ti glottic and supraglot-tic carcinoma of the larynx. Radiother Oncol 1996; 39: 229–33.
  • Kowalski LP, Batista MB, Santos CR, Scopel A, Salvajolli JV, Torloni H. Prognostic factors in T3, NO-1 glottic and trans-glottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy. Arch Otolaryngol Head Neck Surg 1996; 122: 77–82.
  • Tarnawski R, Skladowski K, Maciejewski B. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. Int j Radiat Oncol Biol Phys 1997; 38: 1007–U.
  • Bentzen SM, Johansen LV, Overgaard J, Thames HD. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991; 20: 1197–206.
  • Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the University of Cali-fornia, San Francisco (UCSF) and Stanford University Hospi-tal (SUH) experience. Int J Radiat Oncol Biol Phys 2001; 50: 1172–80.
  • MacKenzie R, Franssen E, Balogh J, Birt D, Gilbert R. The prognostic significance of tracheostomy in carcinoma of the larynx treated with radiotherapy and surgery for salvage. Int J Radiat Oncol Biol Phys 1998; 41: 43–51.
  • Marshak G, Brenner B, Shvero J, et al. Prognostic factors for local control of early glottic cancer. The Rabin Medical Center retrospective study on 207 patients. Int .1 Radiat Oncol Biol Phys 1997; 43: 1009–13.
  • Raitiola H, Pukander J, Laippala P. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis. Acta Otolaryngol 1999; 119: 847 —51.
  • Jakobsen J, Hansen 0, Jorgensen KE, Bastholt L. Lymph node metastases from laryngeal and pharyngeal carcinomas—calcu-lation of burden of metastasis and its impact on prognosis. Acta Oncol 1998; 37: 489–93.
  • Bentzen JK, Hansen HS, Nielsen HW. The prognostic im-portance of volume-weighted mean nuclear volume, mitotic index, and other stereologically measured quantitative para-meters in supraglottic laryngeal carcinoma. Cancer 1999; 86: 2222–8.
  • Raitiola H, Pukander J. Symptoms of laryngeal carcinoma and their prognostic significance. Acta Oncol 2000; 39: 213–6.
  • Geelen CP, Hordijk GJ, Ravasz LA, Terhaard CH. Degree of tumour differentiation as a prognostic factor in advanced laryngeal cancer. Acta Otorhinolaryngol Belg 1995; 49: 1–4.
  • Kokoska MS, Piccirillo JF, el Mofty SK, Emami B, Haughey BH, Schoinick SB. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. Cancer 1996; 78: 1693–700.
  • Morales-Angulo C, Val-Bemal F, Buelta L, Fernandez F, Garcia-Castrillo L, Rama J. Prognostic factors in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg 1998; 119: 548–53.
  • Yilmaz T, Hosal AS, Gedikoglu G, Kaya S. Prognostic significance of histopathological parameters in cancer of the larynx. Eur Arch Otorhinolaryngol 1999; 256: 139–44.
  • Nathan CA, Sanders K, Abreo FW, Nassar R, Glass J. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res 2000; 60: 3599–604.
  • Nicolai P, Redaelli de Zinis LO, Tomenzoli D, et al. Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck 1997; 19: 323–34.
  • Raitiola H, Wigren T, Pukander J. Radiotherapy outcome and prognostic factors in early glottic carcinoma. Auris Nasus Larynx 2000; 27: 153–9.
  • Sanderson RJ, de Boer MF, Damhuis RA, Meeuwis CA, Knegt PP. The influence of alcohol and smoking on the incidence of oral and oropharyngeal cancer in women. Clin Otolaryngol 1997; 22: 444–8.
  • Sanderson RJ, Ironside JA. Squamous cell carcinomas of the head and neck. Br Med J 2002; 325(7368): 822–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.